Stock-Based Compensation Accounting: ASC 718, Options, RSUs, and Fair Value at Grant

Why ASC 718 Changed Everything

Before FAS 123R (now codified as ASC 718, effective 2006 for public companies), companies had a choice: they could measure stock option compensation at intrinsic value (nearly always zero for at-the-money grants) under APB 25, effectively recording no expense for stock options. This produced the absurd result that a company could grant $500 million worth of options to executives and report zero compensation expense. The FASB's conclusion that the fair value of options at grant date represents a real economic cost — and should be recognised as expense — was controversial but correct.

Stock Options vs RSUs vs Performance Awards

Stock options give the employee the right to purchase shares at the exercise price (typically the fair market value on the grant date) for a specified period (typically 10 years), subject to vesting. If the stock price rises above the exercise price, the option has intrinsic value. If the stock price falls below the exercise price, the option is "underwater" and has only time value. Employees are not required to exercise — the option simply lapses if out-of-the-money at expiration.

Restricted Stock Units (RSUs) give the employee a promise to receive shares (or cash equivalent) upon vesting, typically subject to continued employment and sometimes performance conditions. Unlike options, RSUs always have value as long as the stock has value — they do not go underwater. RSUs have become more popular than options in recent decades, particularly in volatile-stock industries, because their value is more predictable for employees.

Performance Share Units (PSUs) tie the number of shares awarded to achievement of performance metrics — revenue targets, EPS goals, total shareholder return relative to peers. They combine the equity upside of RSUs with performance incentive alignment.

Measuring Fair Value at Grant Date

For RSUs, fair value at grant date is simply the stock price on the grant date — straightforward and easily audited. For stock options, fair value must be estimated using an option pricing model because options have time value beyond their intrinsic value (even at-the-money options are worth something because the stock might rise).

The most commonly used model is Black-Scholes. Its inputs:

The expected term of employee options is typically shorter than the contractual term because employees often exercise early. SAB Topic 14 provides a simplified method for estimating expected term when companies lack historical exercise data. The grant-date fair value is locked in — subsequent changes in stock price or volatility do not change the compensation expense already being recognised. This is a key difference from liability-classified awards, which are remeasured every period.

Recognising Expense Over the Vesting Period

Compensation expense is recognised straight-line over the vesting period for awards with graded vesting treated as one award, or accelerated for awards treated tranche-by-tranche (each tranche has its own vesting start and end dates). For a cliff-vesting award (all vest at once after three years):

At vesting (end of Year 3), the APIC balance of $400,000 reflects the cumulative compensation recognised. When shares are issued: Debit APIC $400,000 / Credit Common Stock (par) + APIC (for excess over par). The balance sheet guide explains how APIC fits into the equity section.

Accounting for Forfeitures

When employees leave before vesting, their unvested awards are forfeited and previously recognised expense is reversed. Under ASU 2016-09, companies may choose to account for forfeitures either (a) by estimating expected forfeitures at grant date and recognising expense net of expected forfeitures, or (b) by recognising expense as if all awards will vest and recording the reversal only when forfeitures actually occur (the "actual forfeitures" method). Many companies prefer actual forfeitures for simplicity. The policy choice must be disclosed and applied consistently.

Award Modifications

When a company modifies the terms of an outstanding award (extending the exercise period, lowering the exercise price, accelerating vesting), the modification triggers incremental compensation expense: the difference between the fair value of the modified award and the fair value of the original award immediately before modification. If the modification increases value, incremental expense is recognised. If it decreases value, no benefit is recorded — the original expense continues as if unmodified.

Tax Implications: Excess Tax Benefits and Deferred Tax

Stock-based compensation creates a deferred tax asset (DTA) as expense is recognised for GAAP purposes — the future tax deduction will offset taxable income when the award is exercised or vested. The DTA equals cumulative compensation expense recognised × tax rate. If the eventual tax deduction (based on intrinsic value at exercise) exceeds the GAAP expense, the excess tax benefit goes directly to income tax expense (reducing it) under ASU 2016-09. If the tax deduction is less than GAAP expense, a shortfall (tax deficiency) increases income tax expense.